1,2-Ethanediamine,N1-[(4-chlorophenyl)methyl]-N2,N2-dimethyl-N1-2-pyridinyl- cas no:59-32-5
Synonyms: 1,2-Ethanediamine,N-[(4-chlorophenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl- (9CI); Pyridine,2-[(p-chlorobenzyl)[2-(dimethylamino)ethyl]amino]- (6CI,8CI);2-[(p-Chlorobenzyl)(2-dimethylaminoethyl)amino]pyridine; Allergan S; Avapena;Chlorneoantergan; Chloropyramine; Chloropyribenzamine; Chlorpyramine;Halopyramine; N,N-Dimethyl-N'-(2-pyridyl)-N'-(4-chlorobenzyl)ethylenediamine;N,N-Dimethyl-N'-(p-chlorobenzyl)-N'-(2-pyridyl)ethylenediamine;N-Dimethylaminoethyl-N-p-chlorobenzyl-a-aminopyridine; NSC 241038;N'-[(4-Chlorophenyl)methyl]-N,N-dimethyl-N'-pyridin-2-yl-ethane-1,2-diamine;Subrestin; Suprastin; Synopen; Synopen R; Synpen
Name1,2-Ethanediamine,N1-[(4-chlorophenyl)methyl]-N2,N2-dimethyl-N1-2-pyridinyl-
CAS59-32-5
Synonyms1,2-Ethanediamine,N-[(4-chlorophenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl- (9CI); Pyridine,2-[(p-chlorobenzyl)[2-(dimethylamino)ethyl]amino]- (6CI,8CI);2-[(p-Chlorobenzyl)(2-dimethylaminoethyl)amino]pyridine; Allergan S; Avapena;Chlorneoantergan; Chloropyramine; Chloropyribenzamine; Chlorpyramine;Halopyramine; N,N-Dimethyl-N'-(2-pyridyl)-N'-(4-chlorobenzyl)ethylenediamine;N,N-Dimethyl-N'-(p-chlorobenzyl)-N'-(2-pyridyl)ethylenediamine;N-Dimethylaminoethyl-N-p-chlorobenzyl-a-aminopyridine; NSC 241038;N'-[(4-Chlorophenyl)methyl]-N,N-dimethyl-N'-pyridin-2-yl-ethane-1,2-diamine;Subrestin; Suprastin; Synopen; Synopen R; Synpen
EINECS(EC#)200-421-1
Molecular FormulaC16H20 Cl N3
Molecular Weight289.81
refractive index1.6
Safety
Poison by ingestion, subcutaneous, intravenous, and intraperitoneal routes. When heated to decomposition it emits toxic fumes of Cl− and NOx.
1. |
|
orl-rat LD50:920 mg/kg
|
|
ARZNAD Arzneimittel-Forschung. Drug Research. 25 (1975),1723. |
2. |
|
ipr-rat LD50:104 mg/kg
|
|
ARZNAD Arzneimittel-Forschung. Drug Research. 25 (1975),1723. |
3. |
|
ivn-rat LD50:32,500 µg/kg
|
|
ARZNAD Arzneimittel-Forschung. Drug Research. 25 (1975),1723. |
4. |
|
orl-mus LD50:354 mg/kg
|
|
ARZNAD Arzneimittel-Forschung. Drug Research. 25 (1975),1723. |
5. |
|
ipr-mus LD50:79,200 µg/kg
|
|
ARZNAD Arzneimittel-Forschung. Drug Research. 25 (1975),1723. |
6. |
|
ivn-mus LD50:24,100 µg/kg
|
|
ARZNAD Arzneimittel-Forschung. Drug Research. 25 (1975),1723. |
7. |
|
ipr-gpg LD50:108 mg/kg
|
|
ARZNAD Arzneimittel-Forschung. Drug Research. 25 (1975),1723. |
8. |
|
scu-gpg LD50:142 mg/kg
|
|
ARZNAD Arzneimittel-Forschung. Drug Research. 7 (1957),131. |